北京万泰生物药业股份有限公司关于变更部分回购股份用途并注销的公告

Core Viewpoint - Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. plans to change the purpose of repurchased shares from "for employee stock ownership plan or equity incentives" to "for cancellation and reduction of registered capital" for 729,970 shares [2][8][10] Group 1: Share Repurchase and Cancellation - The company intends to cancel 729,970 shares, which represents 0.0577% of the current total share capital [3][9] - The total number of shares repurchased by the company as of December 21, 2022, was 1,585,320 shares, accounting for 0.1750% of the total share capital at that time [5] - As of the announcement date, 855,350 shares have been used for the 2023 employee stock ownership plan, leaving 729,970 shares unused [8] Group 2: Decision-Making Process - The board of directors and the supervisory board approved the proposal to change the purpose of the repurchased shares on October 15, 2025, and it will be submitted to the shareholders' meeting for approval [4][10][36] - The decision aims to comply with the commitments regarding the usage period of repurchased shares and to enhance investor confidence in the company's long-term value [8][10][35] Group 3: Future Plans - The company will explore other feasible incentive plans to motivate its management team and core technical personnel, aiming to support sustainable development and create value for shareholders [8][12][35]